Abstract:
Malignant tumor blood vessels, with phenotypes that are similar to high endothelial venules (HEVs) in secondary lymphoid organs (SLO), are known as tumor-associated high endothelial venules (TA-HEVs). The formation mechanism of TA-HEVs is similar to that of HEVs. Moreover, TA-HEVs play an important role in promoting the infiltration of lymphocytes into tumor tissues. With ongoing research, the positive effect of TA-HEVs in the context of radiotherapy, chemotherapy, immunotherapy, and antiangiogenic therapy is being elucidated. The clinical value is gradually becoming prominent, and the mechanisms and pathways involved with TA-HEVs are still under investigation.